Latest news

Thumbnail image for Trajenta meets primary endpoint in CAROLINA trial

Trajenta meets primary endpoint in CAROLINA trial

Eli Lilly and Boehringer Ingelheim's Trajenta has been found to demonstrate no increased cardiovascular risk compared to glimepiride in adults with type II diabetes and cardiovascular risk.

15th February 2019

Thumbnail image for New asthma pill to target airway muscles

New asthma pill to target airway muscles

Researchers are developing a new asthma pill Fevipiprant to target airway muscles to decrease attacks, potentially offering the first new oral treatment for asthma in 20 years.

15th February 2019

Thumbnail image for What does it take to win a PharmaTimes award?

What does it take to win a PharmaTimes award?

Earlier this month an event in London - ‘Behind the judging: An exclusive insight into all the major healthcare awards’ - offered a peek into the world of winning a coveted healthcare award.

14th February 2019

Thumbnail image for Oncology sales drive AstraZeneca’s Q4 Earnings

Oncology sales drive AstraZeneca’s Q4 Earnings

AstraZeneca’s published Q4 earnings have shown better than expected results, with new launches and commercial execution delivering full-year sales growth and a very strong final quarter.

14th February 2019

Thumbnail image for AbCellera collaborates with Novartis for antibody discovery

AbCellera collaborates with Novartis for antibody discovery

AbCellera has announced a multi-target, multi-year deal with Novartis, to identify antibodies for ten therapeutic targets in Novartis’ pipeline, using a unique combination of microfluidics, high-throughput imaging, genomics, deep computing and AI.

14th February 2019

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download